Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||||
| Dermatitis | Rash | x | x | x | x | ||
| Dermatitis perioral | x | x | x | x | |||
| Rash | Rash | x | x | x | x | ||
| Folliculitis | Folliculitis | x | x | x | x | ||
| Hypertrichosis | Hypertrichosis | x | x | x | x | ||
| Miliaria | Miliaria | x | x | x | x | ||
| Paraesthesia | Paraesthesia | x | x | ||||
| Pruritus | Pruritus | x | x | x | |||
| Telangiectasia | Telangiectasia | x | x | ||||
| Erythema | Erythema | x | x | x | x | ||
| Urticaria | Urticaria | x | |||||
| Skin atrophy | Skin atrophy | x | x | x | x | ||
| Dry skin | Dry skin | x | x | x | x | ||
| Skin striae | Skin striae | x | x | x | x | ||
| Dermatitis contact | Allergic contact dermatitis | x | x | x | x | ||
| Leukoderma | Leukoderma | x | x | x | x | ||
| Dermatitis acneiform | Acneiform eruption | x | x | x | x | ||
| Infection | Secondary infection | x | x | x | x | ||
| Pain | Stinging | x | x | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||
|---|---|---|---|---|---|---|---|
| Skin disorder | x | x | x | x | |||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |